How much revenue does MJardin make?

MJardin reported 11.44 million CAD in revenue for fiscal year 2020, down 57.2% from 26.70 million CAD in fiscal year 2019. In Q3 2021 revenue was 1.32 million CAD.

What companies are similar to MJardin?

Listed companies of a similar size in the same industry (multi-therapeutic drug manufacturing) include Item 9 Labs Corp. (INLB), Valeo Pharma Inc. (VPHIF), Advantis Corp. (ADVT), RenovaCare, Inc. (RCAR).

MJardin Group, Inc. (MJARF) Stock

About MJardin Group, Inc.

MJardin Group, Inc., through its subsidiaries, cultivates, harvests, processes, and sells cannabis products in Canada and the United States. The company also provides consulting services, including strategic capital and financing, project management services for cultivation, licensure support, facility design, systems implementation, facility and equipment leasing, construction oversight, facility...

At a glance

MJardin reported revenue of 11.44 million CAD for fiscal year 2020, down 57.2% from fiscal year 2019, and net income of -34.84 million CAD. In Q3 2021 (the quarter ended September 30, 2021) revenue was 1.32 million CAD, down 72.7% from a year before.

Figures from company filings; latest fiscal year ended December 31, 2020.

No profile data available.

Disclaimer: This analysis is for informational and educational purposes only and does not constitute financial, investment, tax, or legal advice. Data may be incomplete, delayed, or contain inaccuracies. Consult with a qualified financial advisor before making any investment decisions.